PCA(P)(2023)46 - Pharmaceutical Services Amendments To The Drug Tariff Part 11 Discount Clawback Scale

This Circular provides updated guidance aimed at both community optometry and community pharmacy teams and an updated referral form for the assessment and treatment of minor eye conditions.

This circular advises community pharmacy contractors and Health Boards of a corrective payment in order to deliver contractual requirements for the financial year 2023/24.

This Circular advises NHS Boards and community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot®

This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot® (estradiol hemihydrate) 100 microgram patches

The Chief Pharmaceutical Officer for Scotland has commissioned a review of medicines homecare services. This is being led by Banjamin Hannan, Director of Pharmacy for NHS Fife.

This Circular advises community pharmacy contractors that two of the UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin antibiotic

This circular advises of changes to the Drug Tariff with respect to remuneration arrangements for the dispensing pool month of July.

This circular informs NHS Boards and community pharmacy contractors of the intention to continue funding for Community Pharmacist Practitioner Champions in 2023-24.

Advance payments are made to support contractor cashflow while actual payment for the prescriptions submitted is calculated.

This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot® (estradiol hemihydrate) 100 microgram patches

As touched on in the introduction to pharmacy funding, part of a pharmacy’s income is dependent on the money made on part 7 drug tariff medicines they source and provide on prescription – this profit is often referred to as the margin

This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Utrogestan®

Advance payments are made to support contractor cashflow while actual payment for the prescriptions submitted is calculated.

Over the years as the pharmacy contract has changed, different service payments have been joined together into what we now call the Establishment Payment.

The Pharmaceutical Needs Weighting Payment (PNWP) makes the payment for the additional pharmaceutical needs (and associated workload) from age and deprivation characteristics of the people using the pharmacy.

From April 1st, 2023, until September 30th 2023, there is a separate dispensing pool for the dispensing of prescriptions for patients living in care homes.

The Service Efficiency Payment is for achieving a target level of electronic claiming for prescriptions submitted for pricing by Practitioner Services.

Quality and Service Development supports the operation of a service for coeliac patients and the development of a safety culture

The payments for MCR are made using one of the more complex models in our financial package and is based on the number of people registered for the service (capitation model) at the end of a given month.